Increased Herpes simplex virus 1, Toxoplasma gondii and Cytomegalovirus antibody concentrations in severe mental illness
Infections with Cytomegalovirus (CMV), Herpes simplex virus 1 (HSV1) and Toxoplasma gondii (TG) have been implicated in severe mental illness. All three pathogens have high seroprevalence in the human population, are neurotropic and establish a persistent infection. We hypothesized that exposed (seropositive) patients with severe mental illness would show higher immunoglobulin G (IgG) concentrations than exposed healthy controls (HC). We included 765 patients with severe mental illness (schizophrenia n = 515, bipolar disorder n = 250) and 541 HC. CMV, HSV1 and TG IgG seropositivity and concentrations were measured with immunoassays (seropositivity: CMV, n = 447 patients vs. 296 HC; HSV1, n = 355 vs. 238; and TG, n = 159 vs. 126). Among seropositive participants, patients had higher HSV1 (p < 0.001) and TG (p = 0.003) IgG concentrations than HC. Stratifying by diagnosis, both schizophrenia (p = 0.001) and bipolar disorder (p = 0.001) had higher HSV1 IgG concentrations, while schizophrenia only had higher TG (p = 0.009) and CMV (p = 0.045) IgG concentrations than HC. In SZ, higher HSV1 IgG concentrations were associated with higher psychotic (p = 0.030) and manic (p = 0.008) symptom scores, but only among CMV- or TG-infected patients which suggests synergistic effects. Among all participants, HSV1 IgG concentrations were inversely associated with interleukin-18 (p < 0.001) and positively associated with high-sensitivity C-reactive protein (p = 0.002) and B cell-activating factor (p = 0.004), possibly indicating T cell exhaustion, enhanced inflammation, and increased B-cell response, respectively. Patients with severe mental illness exhibit a heightened immune system response to HSV1, TG, and CMV infections suggesting immune system dysfunction and/or a more severe infection. For HSV1, higher IgG concentrations were linked to a greater clinical burden.
Authors
- Dimitrios Andreou (ORCID: https://orcid.org/0000-0003-4735-3383)
- Tereza Calkova
- Nils Eiel Steen (ORCID: https://orcid.org/0000-0001-6442-1179)
- Kjetil Nordbø Jørgensen (ORCID: https://orcid.org/0000-0002-5751-4809)
- Ingrid Agartz (ORCID: https://orcid.org/0000-0002-9839-5391)
- Ole A. Andreassen (ORCID: https://orcid.org/0000-0002-4461-3568)
- Thor Ueland (ORCID: https://orcid.org/0000-0001-5005-0784)
- Laura A. Wortinger (ORCID: https://orcid.org/0000-0003-2721-3172)
- Lynn Mørch-Johnsen
- Robert H. Yolken
- Ina Drabløs
Institutions
- Oslo University Hospital (NO)
- University Hospital of North Norway (NO)
- Johns Hopkins University (US)
- University of Oslo (NO)
- Johns Hopkins Medicine (US)
- Vestre Viken Hospital Trust (NO)
- Karolinska Institutet (SE)
- Västmanlands sjukhus Västerås (SE)
- Diakonhjemmet Hospital (NO)
- Mälardalen University (SE)
- Stockholm Health Care Services (SE)
- Østfold Hospital Trust (NO)
Publication Details
- Journal
- Translational Psychiatry
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1038/s41398-024-03198-y
- Citations
- 4
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 1.55
Funders
- Karolinska Institutet
- Norges Forskningsråd
- Helse Sør-Øst RHF